|
|
Volumn 24, Issue 3, 2002, Pages 468-470
|
|
Letters to the editor (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
CYCLOOXYGENASE 2;
ISOENZYME;
LACTONE;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
SULFONE;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR RISK;
DATA BASE;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
FLUID RETENTION;
HEART INFARCTION;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
LETTER;
MEDICAL LITERATURE;
PRESCRIPTION;
THROMBOCYTE FUNCTION;
WORLD HEALTH ORGANIZATION;
DRUG SURVEILLANCE PROGRAM;
FACTUAL DATABASE;
METABOLISM;
NOTE;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DATABASES, FACTUAL;
ISOENZYMES;
LACTONES;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
SULFONAMIDES;
SULFONES;
WORLD HEALTH ORGANIZATION;
|
|
EID: 19044378087
PISSN: 01492918
EISSN: 1879114X
Source Type: Journal
DOI: 10.1016/S0149-2918(02)85048-2 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
